Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases

Study ID
NCT02758951

Study type
Interventional

Study phase
Phase 2/Phase 3

Study status
Recruiting

Trial Acronym

CAIRO6

Trial Summary

This is a multicentre, open-label, parallel-group, phase II-III, superiority study that randomises patients with isolated resectable colorectal peritoneal metastases in a 1:1 ratio to receive either perioperative systemic therapy and cytoreductive surgery with HIPEC (experimental arm) or upfront cytoreductive surgery with HIPEC alone (control arm).

More informations

Trial Starting Date

Jun 01,2017

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

358